CoV2-M-IRES-E Citations (4)

Originally described in: Rapid assessment of SARS-CoV-2 evolved variants using virus-like particles.
Syed AM, Taha TY, Tabata T, Chen IP, Ciling A, Khalid MM, Sreekumar B, Chen PY, Hayashi JM, Soczek KM, Ott M, Doudna JA Science. 2021 Nov 4:eabl6184. doi: 10.1126/science.abl6184. PubMed Journal

---

Articles Citing CoV2-M-IRES-E

Articles
Virus-like particle - mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection. Palermo E, Alexandridi M, Di Carlo D, Muscolini M, Hiscott J. Front Cell Infect Microbiol. 2022 Dec 14;12:1079926. doi: 10.3389/fcimb.2022.1079926. eCollection 2022. PubMed
Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry. Sengar A, Cervantes M, Bondalapati ST, Hess T, Kasson PM. J Virol. 2023 May 31;97(5):e0199222. doi: 10.1128/jvi.01992-22. Epub 2023 May 3. PubMed
Development of novel SARS-CoV-2 viral vectors. Liu H, Liu D. Sci Rep. 2023 Aug 11;13(1):13053. doi: 10.1038/s41598-023-40370-8. PubMed
Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants. Lusvarghi S, Stauft CB, Vassell R, Williams B, Baha H, Wang W, Neerukonda SN, Wang T, Weiss CD. PLoS Pathog. 2023 Nov 9;19(11):e1011788. doi: 10.1371/journal.ppat.1011788. eCollection 2023 Nov. PubMed

If you have published an article using this material, please email us at to have your article added to this page.